The drug-buying agency Pharmac has once again said no to funding the 12 month course of the breast cancer drug, Herceptin.
Show status: Off air
Recent stories from Checkpoint
Get the RNZ app
for easy access to all your favourite programmes
for easy access to all your favourite programmes
